Please Scroll Down to See Forums Below
napsgear
genezapharmateuticals
domestic-supply
puritysourcelabs
Research Chemical SciencesUGFREAKeudomestic
napsgeargenezapharmateuticals domestic-supplypuritysourcelabsResearch Chemical SciencesUGFREAKeudomestic

Testosterone Magazine

SunTzu18

New member
Did any of you guys catch the review of a couple of our asian friend's product in the latest issue? They seemed to get pretty good reviews. They did not mention anything about his bathtub.

There was also an article in there stating that Anavar is more toxic than anadrol.....do you guys believe this?

SunTzu18
 
i think andriol would be the safest...but i dont call it a roid tooo damn weak....and anavar is SAFER then anadrol...what jackasses.....
 
HUCKLEBERRY FINNaplex said:
Funny how anavar is actually used to TREAT hepatoxicity...Those guys never cease to amaze...

Hmm. I read that it's used to treat a certain kind of hepatic spot, but I took my liver values on day 10 of ox, 2 weeks later, and again 2 weeks later. I can tell you there ain't no healing going on here... (although SGOT only went above by a bit, not too much. But all the values only went in ONE direction, and that wasn't down.).

Just added accutane to the mix, so can't post conclusive liver results anymore, but I will have had all my levels tested every 2 weeks and will post them at the end of teh cycle so y'all can see what some of the newer drugs do, i.e. femara, as well as accutane + 17aa, as well as btg vs ipvar.

L8R.
 
SunTzu18 said:
Did any of you guys catch the review of a couple of our asian friend's product in the latest issue? They seemed to get pretty good reviews. They did not mention anything about his bathtub.

There was also an article in there stating that Anavar is more toxic than anadrol.....do you guys believe this?

SunTzu18

Can you link to the article? I couldn't find it anywhere.
 
Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, Simon D, Galambos JT

Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

The present studies were designed to provide careful measures of effects of oxandrolone, an anabolic steroid, intravenous nutritional supplementation, and the combination of these two treatments on liver functions, metabolic balances, nitrogen metabolism, and nutritional status in patients with moderate to severe alcoholic hepatitis. Of 43 patients originally recruited, 39 (19 men, 20 women) with typical clinical and laboratory features of alcoholic hepatitis (11 Child's-Pugh class B; 28 class C) were admitted to a metabolic unit and completed a 35-day three-phase protocol. Phase I was a 10-day baseline period of observation, during which routine and special quantitative tests of liver function (galactose and antipyrine metabolism), a 7-day elemental balance study, and a 15N, 13C-leucine metabolism study were done. Phase II was a 21-day treatment period during which patients were randomly assigned to receive one of four regimens: 1) standard therapy, consisting of abstinence, a balanced, nutritionally adequate diet, and multivitamins; 2) oxandrolone (20 mg orally four times a day) plus standard therapy; 3) nutritional supplementation, consisting of 2 L daily of 3.5% crystalline amino acids (in 5% dextrose), given by peripheral vein; or 4) a combination of oxandrolone and nutritional supplementation, along with standard therapy. Metabolic balances were repeated during phase II. Phase III was 2 or 3 days posttreatment, during which special studies of liver functions and volumes and leucine metabolism were repeated. All patients who completed phase I of study and were randomly allocated to one of the four treatment groups completed the subsequent two phases. Overall, with time, patients showed highly significant improvements in most clinical and laboratory features. For most standard laboratory tests (e.g., serum albumin, transferrin, prothrombin time) improvements were more marked in patients treated with nutritional supplementation and/or oxandrolone than in those given standard therapy alone. Liver volumes fell in all treatment groups, with greater improvement in those treated with nutritional supplementation. Improvements in galactose and antipyrine metabolism rates were significant only in those treated with nutritional supplementation or oxandrolone. Effects of treatments on metabolic balances, nitrogen metabolism, and measures of nutrition are described in this issue in a companion paper. We conclude that the addition of nutritional supplementation and oxandrolone to standard therapy of moderately severe or severe alcoholic hepatitis is well tolerated, and leads to more rapid improvement in the laboratory parameters measured.
 
I also remember seeing a study that showed Oxandrolone exhibited no liver toxicity when given to cirrhosis patients at a dosage of 80mg a day. Anadrol on the other hand......
 
HUCKLEBERRY FINNaplex said:
Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, Simon D, Galambos JT

Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

The present studies were designed to provide careful measures of effects of oxandrolone, an anabolic steroid, intravenous nutritional supplementation, and the combination of these two treatments on liver functions, metabolic balances, nitrogen metabolism, and nutritional status in patients with moderate to severe alcoholic hepatitis. Of 43 patients originally recruited, 39 (19 men, 20 women) with typical clinical and laboratory features of alcoholic hepatitis (11 Child's-Pugh class B; 28 class C) were admitted to a metabolic unit and completed a 35-day three-phase protocol. Phase I was a 10-day baseline period of observation, during which routine and special quantitative tests of liver function (galactose and antipyrine metabolism), a 7-day elemental balance study, and a 15N, 13C-leucine metabolism study were done. Phase II was a 21-day treatment period during which patients were randomly assigned to receive one of four regimens: 1) standard therapy, consisting of abstinence, a balanced, nutritionally adequate diet, and multivitamins; 2) oxandrolone (20 mg orally four times a day) plus standard therapy; 3) nutritional supplementation, consisting of 2 L daily of 3.5% crystalline amino acids (in 5% dextrose), given by peripheral vein; or 4) a combination of oxandrolone and nutritional supplementation, along with standard therapy. Metabolic balances were repeated during phase II. Phase III was 2 or 3 days posttreatment, during which special studies of liver functions and volumes and leucine metabolism were repeated. All patients who completed phase I of study and were randomly allocated to one of the four treatment groups completed the subsequent two phases. Overall, with time, patients showed highly significant improvements in most clinical and laboratory features. For most standard laboratory tests (e.g., serum albumin, transferrin, prothrombin time) improvements were more marked in patients treated with nutritional supplementation and/or oxandrolone than in those given standard therapy alone. Liver volumes fell in all treatment groups, with greater improvement in those treated with nutritional supplementation. Improvements in galactose and antipyrine metabolism rates were significant only in those treated with nutritional supplementation or oxandrolone. Effects of treatments on metabolic balances, nitrogen metabolism, and measures of nutrition are described in this issue in a companion paper. We conclude that the addition of nutritional supplementation and oxandrolone to standard therapy of moderately severe or severe alcoholic hepatitis is well tolerated, and leads to more rapid improvement in the laboratory parameters measured.



This dude doesnt stop with the studies, I love, Great for the board.:D
 
Top Bottom